Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Stevens

Showing results (31-40 of 279) with videos related to

Pageof 28
Sort By:
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Treatment strategies for Aspergillus infectionsTom M. Chiller, David A. Stevens
Immunological Investigations|October 12, 2011
Aspergillosis in the 'nonimmunocompromised' hostDavid A Stevens, George L Melikian
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Orogastrointestinal model of mucosal and disseminated candidiasisKarl V Clemons, David A Stevens
Journal of Fungi (Basel, Switzerland)|January 27, 2018
Verapamil Inhibits Aspergillus Biofilm, but Antagonizes VoriconazoleHasan Nazik, Varun Choudhary, David A Stevens
Cytokine|August 30, 2002
Regulation of bronchoalveolar macrophage proinflammatory cytokine production by dexamethasone and granulocyte-macrophage colony-stimulating factor after stimulation by Aspergillus conidia or lipopolysaccharideMarika Kamberi, Elmer Brummer, David A Stevens
Journal of Fungi (Basel, Switzerland)|June 27, 2023
Mortality in ICU Patients with COVID-19-Associated Pulmonary AspergillosisAnna Beltrame, David A Stevens, Donna Haiduven
The Journal of Infectious Diseases|February 25, 2003
Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidiaElmer Brummer, Marika Kamberi, David A Stevens
Pathogens (Basel, Switzerland)|April 30, 2021
<i>Pseudomonas aeruginosa</i> Virulence Factors Support Voriconazole Effects on <i>Aspergillus fumigatus</i>Gabriele Sass, Pallabi Shrestha, David A Stevens
Cytokine|October 28, 2006
IL-12 induction of resistance to pulmonary blastomycosisElmer Brummer, V Vinoda, David A Stevens
Pathogens (Basel, Switzerland)|October 25, 2024
Anti-Fungal (<i>Aspergillus fumigatus</i>) Activity of <i>Pseudomonas aeruginosa</i> in Cystic Fibrosis Synthetic SputumGabriele Sass, Satya Kethineni, David A Stevens
Pageof 28

Showing results (31-40 of 279) with videos related to

Sort By:
Pageof 28
Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 11, 2001
Treatment strategies for Aspergillus infectionsTom M. Chiller, David A. Stevens
Immunological Investigations|October 12, 2011
Aspergillosis in the 'nonimmunocompromised' hostDavid A Stevens, George L Melikian
Methods in Molecular Biology (Clifton, N.J.)|February 14, 2012
Orogastrointestinal model of mucosal and disseminated candidiasisKarl V Clemons, David A Stevens
Journal of Fungi (Basel, Switzerland)|January 27, 2018
Verapamil Inhibits Aspergillus Biofilm, but Antagonizes VoriconazoleHasan Nazik, Varun Choudhary, David A Stevens
Cytokine|August 30, 2002
Regulation of bronchoalveolar macrophage proinflammatory cytokine production by dexamethasone and granulocyte-macrophage colony-stimulating factor after stimulation by Aspergillus conidia or lipopolysaccharideMarika Kamberi, Elmer Brummer, David A Stevens
Journal of Fungi (Basel, Switzerland)|June 27, 2023
Mortality in ICU Patients with COVID-19-Associated Pulmonary AspergillosisAnna Beltrame, David A Stevens, Donna Haiduven
The Journal of Infectious Diseases|February 25, 2003
Regulation by granulocyte-macrophage colony-stimulating factor and/or steroids given in vivo of proinflammatory cytokine and chemokine production by bronchoalveolar macrophages in response to Aspergillus conidiaElmer Brummer, Marika Kamberi, David A Stevens
Pathogens (Basel, Switzerland)|April 30, 2021
<i>Pseudomonas aeruginosa</i> Virulence Factors Support Voriconazole Effects on <i>Aspergillus fumigatus</i>Gabriele Sass, Pallabi Shrestha, David A Stevens
Cytokine|October 28, 2006
IL-12 induction of resistance to pulmonary blastomycosisElmer Brummer, V Vinoda, David A Stevens
Pathogens (Basel, Switzerland)|October 25, 2024
Anti-Fungal (<i>Aspergillus fumigatus</i>) Activity of <i>Pseudomonas aeruginosa</i> in Cystic Fibrosis Synthetic SputumGabriele Sass, Satya Kethineni, David A Stevens
Pageof 28